Commonwealth Equity Services LLC lifted its position in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 5.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,856 shares of the medical instruments supplier’s stock after buying an additional 208 shares during the period. Commonwealth Equity Services LLC’s holdings in West Pharmaceutical Services were worth $378,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Texas Permanent School Fund increased its position in shares of West Pharmaceutical Services by 4.8% in the fourth quarter. Texas Permanent School Fund now owns 48,477 shares of the medical instruments supplier’s stock worth $4,752,000 after acquiring an additional 2,207 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in West Pharmaceutical Services by 30.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 691,502 shares of the medical instruments supplier’s stock valued at $67,788,000 after acquiring an additional 159,814 shares during the last quarter. BlackRock Inc. boosted its stake in West Pharmaceutical Services by 4.5% during the 4th quarter. BlackRock Inc. now owns 6,939,493 shares of the medical instruments supplier’s stock valued at $680,279,000 after acquiring an additional 298,898 shares during the last quarter. Trillium Asset Management LLC boosted its stake in West Pharmaceutical Services by 4.1% during the 4th quarter. Trillium Asset Management LLC now owns 11,807 shares of the medical instruments supplier’s stock valued at $1,157,000 after acquiring an additional 461 shares during the last quarter. Finally, Mission Wealth Management LP bought a new position in West Pharmaceutical Services during the 4th quarter valued at $233,000. 94.39% of the stock is currently owned by institutional investors and hedge funds.
WST traded down $0.12 on Friday, reaching $111.52. 379,805 shares of the company traded hands, compared to its average volume of 368,453. West Pharmaceutical Services Inc. has a 52-week low of $84.91 and a 52-week high of $125.09. The company has a market capitalization of $8.22 billion, a PE ratio of 39.69, a PEG ratio of 3.54 and a beta of 1.25. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.40 and a current ratio of 3.15.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Wednesday, April 17th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.54%. The ex-dividend date is Tuesday, April 16th. West Pharmaceutical Services’s dividend payout ratio is 21.35%.
Separately, Zacks Investment Research downgraded shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Saturday, January 19th.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
See Also: Mutual Funds
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.